SEC Form D · Amendment · filed March 29, 2019
LifeMine Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (16)
Weiqing L. Zhou · Cambridge, MAExecGregory L. Verdine · Cambridge, MAExec · DirectorYanling L. Cao · Cambridge, MADirectorKrishna L. Yeshwant · Cambridge, MADirectorJonathan N. Abe · CAMBRIDGE, MAExec · DirectorOmar N. Blayton · CAMBRIDGE, MADirectorTravis J. Putnam · Los Angeles, CAExecHelen Thornton · Hamilton, BermudaDirectorRichard L. Klausner · Cambridge, MADirectorWei L. Li · Cambridge, MADirectorRich Levandov · San Francisco, CAExecBrady Bohrmann · San Francisco, CAExec · DirectorKaiwalya Kher · San Francisco, CADirectorMichael Bach · San Francisco, CADirectorRichard L. Klausner · Cambridge, MADirectorWei L. Li · Cambridge, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗